RESEARCH

Crunchfish: Chairman and CEO secure funding while strategic positioning continues to expand

Analys, Research

Not quite in the form we had expected, but with the Chairman and CEO committing to subscribe for...

Read More

NANEXA: Funding secured as semaglutide pivot sharpens commercial focus

Analys, Research

Following the breakthrough license deal with Moderna, a global leader in mRNA therapeutics, in...

Read More

CRUNCHFISH: System-level positioning in place, commercial traction still pending

Analys, Research

Following last year’s breakthrough integration into India’s payment ecosystem, Crunchfish...

Read More

NANEXA: First license with Moderna an important validation of PharmaShell

Analys, Research

The announcement of Nanexa’s first licensing deal marks a meaningful validation of the...

Read More

NANEXA: Intensified focus on deals amid growing funding pressure

Analys, Research

Nanexa’s Q3 report underscores a pivotal moment for the company. While interest in its...

Read More

CINDRIGO HOLDINGS: Powering Europe’s clean baseload transition with LSE listing and first revenues

Research

Johan Widmark | 2025-10-30 17:00  Read the report in PDF here Executive Summary  With the...

Read More

PROLIGHT: Financing and partner interest strengthen case ahead of regulatory study

Analys, Research

Johan Widmark | 2025-08-29 08:00 READ REPORT IN PDF In Q2, Prolight reported initial positive data...

Read More

CRUNCHFISH: Improved outlook with NPCI adoption and global validation

Analys, Research

Crunchfish’s new go-to-market strategy for offline payments, splitting the solution into...

Read More